• The Loop
  • Posts
  • 🔆 Gen AI in Health Tech: A Neuroscientist's Perspective

🔆 Gen AI in Health Tech: A Neuroscientist's Perspective

Dolphin chatter, slipping AI safety reports, and a scientist's view of AI

Was this email forwarded to you? Sign up here

🗞️ Issue 66 // ⏱️ Read Time: 5 min

Hello 👋

As health tech founders increasingly turn to GenAI, how do you separate hype from reality? This week, we're sharing key insights from Dr. Anna McLaughlin, a neuroscientist and founder, on the promises and pitfalls of AI in healthcare. We'll highlight direct quotes from her recent blog post and Lumiera’s perspective on these critical issues.

In this week's newsletter

What we’re talking about: The promises and perils of using GenAI in health tech, with insights from a neuroscientist.

How it’s relevant: Over 80% of researchers already use tools like ChatGPT in their research workflows, which means it’s never been more important to understand the red flags amidst the excitement.

Why it matters: The proper integration of AI in healthcare requires balancing technological innovation with human expertise to ensure safe, effective, and scientifically sound solutions for patients and providers.

Big tech news of the week…

☄️ A high school student from California has made a groundbreaking discovery in astronomy, developing an AI algorithm to identify 1.5 million previously unknown objects in space. 

🇪🇺 Meta has confirmed plans to train its AI models on content shared by its adult users in the EU. While the company stresses this as a transparent and compliant approach that will benefit its European users, there is open debate on the effectiveness and fairness of their “opt-out” system for this kind of data collection. 

🐬 Google has unveiled DolphinGemma, an AI model designed to decode dolphin vocalizations, in collaboration with researchers from Georgia Tech and the Wild Dolphin Project.

🦺 OpenAI launched a new family of AI models, GPT-4.1, without the safety report that typically accompanies their model releases. This avoidance is part of a growing trend of leading AI labs lowering their reporting standards. While not mandated by law or regulation, these reports are seen as good-faith efforts to support independent research and promote accountability.

Meet the Founder of Sci-Translate

Dr Anna McLaughlin, Neuroscientist & Founder

With a PhD in Neuroscience & Psychology from King's College London and extensive research experience, Anna is uniquely positioned to bridge the gap between complex science and practical application. She founded Sci-Translate to help businesses create science-backed health products and interventions.

Lumiera’s Top 5 Takeaways

Here are our favorite quotes and expert insights after reading “Science in the Age of AI: Can We Trust Gen AI in Health Tech?”.

Subscribe to keep reading

This content is free, but you must be subscribed to The Loop to continue reading.

Already a subscriber?Sign In.Not now